August 08, 2020 14:49 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Kashmir: Army soldier slipped to death near LoC in Kupwara | BJP MP Chikhalikar tests positive for Covid-19 | Sushant death probe: Rhea Chakraborty reaches ED office after postponement of summon plea rejected | India reports 62,538 cases, 886 fatalities in past 24 hours | India's COVID-19 cases breach 2 million mark
GVK BIO and LifeArc celebrates 10th anniversary of partnership

GVK BIO and LifeArc celebrates 10th anniversary of partnership

India Blooms News Service | @indiablooms | 16 May 2019, 10:07 am

Kolkata, May 16 (IBNS): Hyderabad-based GVK BIO, a leading global Contract Research and Development Organisation (CRDO), and LifeArc, one of UK’s top medical research charities,recently observed the 10th anniversary of their partnership.

The collaboration between LifeArc and GVK BIO focuses on advancing novel research ideas into potential medicines that can make a significant difference to patients.

LifeArc’s approach involves levering partnerships with academia and leading service organizations to advance discoveries into promising medicines. 

Over the past decade, LifeArc scientific teams have focused their efforts on modulating novel targets with therapeutic potential in diseases where there is patient need, with the GVK BIO team assisting in synthesizing complex molecules rapidly and cost effectively to drive iterative improvement in efficacy and safety.

Promising novel chemical entities discovered from this partnership have been either advanced by LifeArc into clinical development, or have been licensed out to leading global pharmaceutical companies, including a recently announced deal in neuroscience.

As the partnership evolved from a tactical relationship into a preferred partnership, the GVK BIO team has augmented LifeArc’s internal biology efforts, by supporting biochemical assays, carrying out drug metabolism and pharmacokinetics profiling studies, and soon, will be developing cell-based assays and running protein expression and purification studies. 

“It has been our privilege to have collaborated with LifeArc and its world class team of scientists that have delivered medicines such as Keytruda, Tysabri, and Entyvio among others," said Manni Kantipudi, Director & Chief Executive Officer, GVK BIO.

“The longevity of this partnership, and the transformative results of the collaboration, serve as a testament to the capabilities of the GVK BIO team and its commitment to work with customers to make a difference in human life. We look forward to continuing this successful relationship with LifeArc in the coming years, he said.”

Commenting on the partnership, Melanie Lee, Chief Executive Officer, LifeArc said, “At LifeArc, we’re committed to translating scientific innovation to benefit patients. Our partnership with GVK BIO is a strong example of how shared goals and collaboration can create real value.”


Image Credit: GVK BIO/Facebook